Penbrook Management LLC Novo Nordisk A S Transaction History
Penbrook Management LLC
- $145 Million
- Q3 2024
A detailed history of Penbrook Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Penbrook Management LLC holds 312,500 shares of NVO stock, worth $26.6 Million. This represents 25.58% of its overall portfolio holdings.
Number of Shares
312,500
Previous 312,600
0.03%
Holding current value
$26.6 Million
Previous $44.6 Million
16.61%
% of portfolio
25.58%
Previous 28.92%
Shares
20 transactions
Others Institutions Holding NVO
# of Institutions
1,957Shares Held
320MCall Options Held
5.49MPut Options Held
7.78M-
Jennison Associates LLC20.2MShares$1.72 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.22 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.22 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.13 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$1.04 Billion3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $192B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...